Local
Blood Test Detects CTE in Living Former Football Players, BU-Led Study Finds
A Boston University and Banner Health study published in JAMA identified a blood protein, eMTBR-tau, that was significantly elevated in former football players who were later found to have high-stage CTE at autopsy, offering a potential path to diagnosing the disease in living patients for the first time.
For the first time, researchers have found a blood-based method that may allow CTE to be detected in living people, according to a study published Thursday in the Journal of the American Medical Association.
The research, led by Boston University and Banner Health, a nonprofit health system based in Phoenix, focused on 21 former football players who had blood drawn while alive and later donated their brains for autopsy. The study found that levels of a blood protein called endogenously cleaved microtubule-binding region tau, or eMTBR-tau, were significantly higher in participants who had high-stage CTE compared with those who had low-stage or no CTE.
CTE, or chronic traumatic encephalopathy, is a progressive neurodegenerative disease linked to repeated blows to the head. It currently can be diagnosed only after death through autopsy. The disease is associated with memory loss, impaired judgment and behavioral changes, particularly in later stages, and there is no cure.
"It's a game-changer," said Michael Alosco, co-senior author of the study and co-director of clinical research at the BU CTE Center. "Because if this study holds up with future research, if we validate it, then you're talking about a biomarker that can help us to detect it during life."
Of the 21 former players, 18 were found at autopsy to have CTE, 16 of them at a high stage. Three had no CTE. Twelve of the participants had played professionally, seven in college and two in high school. Eleven of the 12 professional players had high-stage CTE, as did four of the seven college players and one of the two high school players. The median age at death for participants with CTE was 73, compared with 51 for those without.
Alosco cautioned that the work remains in the discovery phase. "We have a lot more work to do, but this study clearly showed quite a strong signal for this blood test in terms of detecting CTE neuropathology at death," he said.
A reliable biomarker would allow researchers to enroll the right participants in clinical trials and monitor whether experimental treatments are working, Alosco said. The blood test would be used alongside other diagnostic methods to confirm a CTE diagnosis.
One participant was Ron "Bogie" Edwards, who played football and basketball at Utah State University and later in the Canadian Football League and Continental Football League, and tried out for the Denver Broncos. He died last year at 79. According to his son, Rogue Edwards, his father became increasingly forgetful, repeated stories, got lost and was diagnosed with dementia. An autopsy showed advanced CTE.
"I am so excited that my dad's final contribution to the world can potentially help millions," Rogue Edwards said. "He always tried to help others, and I am so thankful for the work the BU team has been able to do to bring this to the forefront, and help people moving forward."
When he learned of the study results, Edwards said, "I was so overjoyed. It's everything my dad wanted. For him to be part of that, to contribute to that, is so special."
The findings arrive amid growing scrutiny of brain injuries in football. A study published in August examined the brains of former NFL players who died between 2016 and 2021 and found that at least one in four had CTE. A subsequent study in October estimated that three out of four players who died between 2008 and 2023 most likely had the disease, the highest estimate to date.
High-profile cases have included linebacker Junior Seau and tight end Aaron Hernandez, both of whom died by suicide.
Larger studies will be needed to confirm the accuracy of the blood test findings, Alosco said, as well as further research to identify potential treatments.
If you or someone you know is in crisis, call or text 988 to reach the Suicide and Crisis Lifeline or chat live at 988lifeline.org.